Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-07-11
2006-07-11
Kaushal, Sumesh (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S069100, C435S320100, C435S325000, C435S455000, C424S093100, C424S093200, C424S093210
Reexamination Certificate
active
07074772
ABSTRACT:
The invention concerns an expressible nucleic acid construct, which contains only the sequence information necessary for expressing a gene for RNA or protein synthesis. Expression constructs of this type can be used in gene therapy and genetic vaccination and avoid many of the risks associated with constructs today. The invention further concerns the possibility of improving the conveying of the construct into cells or tissue by covalent linkage of the construct, for example to particles of peptides.
REFERENCES:
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5584807 (1996-12-01), McCabe
patent: 5589466 (1996-12-01), Felgner et al.
patent: 6451593 (2002-09-01), Wittig et al.
patent: 0686697 (1995-12-01), None
patent: 0732395 (1996-09-01), None
patent: 9626270 (1996-08-01), None
patent: 9632473 (1996-10-01), None
Johnston et al Gen. Eng. 15:225-236, 1993.
Lopez-Fuertes et al, DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice. Vaccine. 21(3-4):247-5, 2002.
Moreno et al, DNA immunisation with minimalistic expression constructs. Vaccine. 2(13-14):1709-16, 2004.
“Immunization by Direct DNA Inoculation Induces Rejection of Tumor Cell Challenge” Wang et al., Human Gene Therapy 6:407-418 (Apr. 1995).
“Identification of Wild-Type and Mutant p53 Peptides Binding to HLA-A2 Assessed by a Peptide Loading-Deficient Cell Line Assay and a Novel Major Histocompatibility Complex Class I Peptide Binding Assay” Stuber et al., Eur. J. Immunol. 1994. 24:765-768.
“Particle-Mediated Gene Transfer of Granulocyte-Macrophage Colony-Stimulating Factor cDNA to Tumor Cells: Implications for a Clinically Relevant Tumor Vaccine” Mahvi et al., Human Gene Therapy 7: 1535-1543 (Aug. 20, 1996).
“Ex Vivo Regulation of Specific Gene Expression by Nanomolar Concentration of Double-Stranded Dumbbell Oligonucleotides” Clusel et al., Nucleic AcidssResearch, 1993, vol. 21, No. 15, 3405-3411.
“Dendritic Cells as Initiators of Tumor Immune Responses: A Possible Strategy for Tumor Immunotherapy?” Grabbe et al., Immunology Today. vol. 16, No. 3 1995. 117-121
“Sequence-Independent Inhibition of RNA Transcription by DNA Dumbbells and Other Decoys” Lim et al., Nucleic Acids Research. 1997, vol. 25, No. 3, 575-581.
“A New Paptide Vector for Efficient Delivery of Oligonucleotides Into Mammalian Cells” Morris et al., Nucleic Acids Research, 1997, vol. 25, No. 14, 2730-2736.
“Improved Biological Activity of Antisense Oligonucleotides Conjugated to a Fusogenic Peptide” Bongartz et al., Nucleic Acids Research, 1994, vol. 22, No. 22, 4681-4688.
“The Influence of Endosome-Disruptive Peptides on Gene Transfer Using Synthetic Virus-Like Gene Transfer Systems” Plank et al., The Journal of Biôlogical Chemistry, vol. 269, No. 17, Apr. 29, 1994, pp. 12918-12924.
“Linear Mitochondrial DNAs of Yeasts: Closed-Loop Structure of the Termini and Possible Linear-Circular Conversion Mechanisms,” Dipouël et al., Mölecular and Cellular Biology, Apr. 1993, p. 2315-2323.
“Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein” Ulmer et al., Science, vol. 259, Mar. 19, 1993, p. 1745-1749.
“Comparison of Organic Monolayers on Polycrystalline Gold Spontaneously Assembled From Solutions Containing Dialkyl Disulfides or Alkanethiols” Biebuyck et al., Langmuir 1994, 10, 1825-1831.
“Regression of Established Murine Carcinoma Metastases Following Vaccination With Tumour-Associated Antigen Peptides” Mandelboim et al. . Nature Medicine, vol. 1, No. 11, Nov. 1995, p. 1179-1183.
Junghans Claas
Wittig Burghardt
Kaushal Sumesh
Mologen AG
Nils H. Ljungman & Associates
LandOfFree
Design principle for the construction of expression... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Design principle for the construction of expression..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Design principle for the construction of expression... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3598335